(Q33763420)

29 July 2017

1 reference

title

The female sex hormone oestrogen as a neuroprotectant (English)

1 reference

29 July 2017

1 reference

Behl C

1

1 reference

PubMed ID

10542441

29 July 2017

Holsboer F

series ordinal

2

1 reference

PubMed ID

10542441

29 July 2017

language of work or name

1 reference

1 November 1999

1 reference

Trends in Pharmacological Sciences

29 July 2017

1 reference

29 July 2017

20

1 reference

29 July 2017

441-444

1 reference

29 July 2017

11

1 reference

Steroid hormone receptors and their regulation by phosphorylation

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Estrogen actions in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Effects of growth factors and estrogen on the development of septal cholinergic neurons from the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

ERbeta: a novel estrogen receptor offers the potential for new drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Transcription factor NF-kappaB: friend or foe of neurons?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Membrane sex-steroid receptors in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Sex-steroid actions on neurotransmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Rapid Action of 17 -Estradiol on Kainate-Induced Currents in Hippocampal Neurons Lacking Intracellular Estrogen Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

The effects of steroid hormones on electrical activity of excitable cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Neuroprotection against oxidative stress by estrogens: structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Advances and challenges in the prevention and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Amyloid, the presenilins and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Oxidative alterations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901392-9

7 January 2021

10.1016/S0165-6147(99)01392-9

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10542441